Download PDF
Thromb Haemost 1985; 54(03): 661-664
DOI: 10.1055/s-0038-1660092
Original Article
Schattauer GmbH Stuttgart

Hepatic Clearance of Tissue-Type Plasminogen Activator in Rats

J J Emeis
The TNO Gaubius Institute for Cardiovascular Research, Leiden, The Netherlands
,
C M van den Hoogen
The TNO Gaubius Institute for Cardiovascular Research, Leiden, The Netherlands
,
D Jense
The TNO Gaubius Institute for Cardiovascular Research, Leiden, The Netherlands
› Author Affiliations
Further Information

Publication History

Received 26 April 1985

Accepted 31 July 1985

Publication Date:
19 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

The clearance of tissue-type plasminogen activator (t-PA) was studied, in rats, by use of a functional assay for t-PA. Half-lives in the circulation were about one minute both for human (melanoma cell-derived) t-PA and for the rat’s own t-PA. The clearance of t-PA required an intact liver blood flow. In isolated liver perfusion experiments the hepatic extraction of t-PA did not require any plasma proteins, including fast-acting t-PA inhibitor. Competition experiments, using monosaccharides, suggested that known hepatic glycoprotein receptors were not involved in hepatic t-PA extraction.

Keywords

Rat - Tissue-type plasminogen activator - Clearance - Liver - Carbohydrate - Tunicamycin
 

  • References

  • 1 Chmielewska J, Rânby M, Wiman S. Evidence for a rapid inhibitor to tissue plasminogen activator in plasma. Thromb Res 1983; 31: 427-436
    CrossrefPubMedGoogle Scholar
  • 2 Verheijen JH, Chang GT G, Kluft C. Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasma. Thromb Haemostas 1984; 51: 392-395
    PubMedGoogle Scholar
  • 3 Kruithof EK O, Tran-Thang C, Ransijn A, Bachmann F. Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma. Blood 1984; 64: 907-913
    PubMedGoogle Scholar
  • 4 Wiman B, Chmielewska J, Rânby M. Inactivation of tissue plasminogen activator in plasma. Demonstration of a complex with a new rapid inhibitor. J Biol Chem 1984; 259: 3644-3647
    PubMedGoogle Scholar
  • 5 Thorsen S, Philips M. Isolation of tissue-type plasminogen activator-inhibitor complexes from human plasma. Biochim Biophys Acta 1984; 802: 111-118
    CrossrefPubMedGoogle Scholar
  • 6 Rijken DC, Wijngaards G, Welbergen J. Relationship between uterine tissue plasminogen activator and the activators in blood and vascular wall. Thromb Res 1980; 18: 815-830
    CrossrefPubMedGoogle Scholar
  • 7 Kristensen P, Larssen LI, Nielsen LS, Grøndahl-Hansen J, Andreasen PA, Danø K. Human endothelial cells contain one type of plasminogen activator. FEBS Letters 1984; 168: 33-37
    CrossrefPubMedGoogle Scholar
  • 8 Markwardt G. Gefäßwand und Fibrinolyse. Arzneimittelforschung/ Drug Research 1983; 33: 1370-1374
    PubMedGoogle Scholar
  • 9 Nolf P. Les modifications de la coagulation du sang chez le chien après l’extirpation du foie. Arch Int Physiol 1905; 3: 01-43
    PubMedGoogle Scholar
  • 10 Wasantapruek S, Von Kaulla KN. A serial micro-fibrinolysis test and its use in rats with liver bypass. Thrombos Diathes Haemorrh 1966; 15: 284-293
    PubMedGoogle Scholar
  • 11 Von Kaulla KN, Von Kaulla E, Wasantapruek S. Rapid increase of fibrinolytic activity in pig and rat after exclusion of the liver from the circulation and its control by various organs. Acta Hepato-Gastroen-terol 1979; 26: 4-8
    PubMedGoogle Scholar
  • 12 Emeis JJ. Perfused rat hindlegs. A model to study plasminogen activator release. Thromb Res 1983; 30: 195-203
    CrossrefPubMedGoogle Scholar
  • 13 Korninger C, Stassen JM, Collen D. Turnover of human extrinsic (tissue-type) plasminogen activator in rabbits. Thromb Haemostas 1981; 46: 658-661
    PubMedGoogle Scholar
  • 14 Nilsson S, Matsson Ch, Häggroth L. The elimination and the thrombolytic effect of the plasminogen activator in normal and hepatectomized rabbits. Thromb Haemostas 1983; 50: 296 (Abstr.)
    PubMedGoogle Scholar
  • 15 Nilsson T, Wallén P, Mellbring G. In vivo metabolism of human tissue-type plasminogen activator. Scand J Haematol 1984; 33: 49-53
    PubMedGoogle Scholar
  • 16 Emeis JJ. Hepatic clearance of tissue-type plasminogen activator in rats. Thromb Haemostas 1983; 50: 295 (Abstr)
    PubMedGoogle Scholar
  • 17 Rijken DC, Collen D. Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. J Biol Chem 1981; 256: 7035-7041
    PubMedGoogle Scholar
  • 18 Kluft C, Van Wezel AL, Van der Velden CAM, Emeis JJ, Verheijen JH, Wijngaards G. Large-scale production of extrinsic (tissue-type) plasminogen activator from human melanoma cells. In: Advances in biotechnological processes Mizrahi A, Van Wezel AL. (Eds) A R Liss Inc; New York: 1983. 2 097-110
  • 19 Verheijen JH, Mullaart E, Chang GT G, Kluft C, Wijngaards G. A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma. Thromb Haemostas 1982; 48: 266-269
    PubMedGoogle Scholar
  • 20 Gaffney PJ, Curtis AD. A collaborative study of a proposed international standard for tissue plasminogen activator (t-PA). Thromb Haemostas 1985; 53: 134-136
    PubMedGoogle Scholar
  • 21 Gallimore MJ. Effect of diluents on blood clot lysis. J Clin Path 1967; 20: 234-238
    CrossrefPubMedGoogle Scholar
  • 22 Emeis JJ. Platelets and the dilute blood clot lysis. In: Haemostasis and Thrombosis Neri Serneri GG, Prentice CRM. (Eds) Academic Press; New York: 1979: 769-772
  • 23 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-275
    PubMedGoogle Scholar
  • 24 Emeis JJ, Kluft C. PAF-acether-induced release of tissue-type plasminogen activator from vessel walls. Blood 1985; 66: 86-91
    PubMedGoogle Scholar
  • 25 Achord DT, Brot FE, Bell CE, Sly WS. Human β-glucuronidase: in vivo clearance and in vitro uptake by a glycoprotein recognition system on reticuloendothelial cells. Cell 1978; 15: 269-278
    CrossrefPubMedGoogle Scholar
  • 26 Tkacz JS, Lampen JO. Tunicamycin inhibition of polyisoprenyl N-acetyl-glucosaminyl pyrophosphate formation in calf liver microsomes. Biochem Biophys Res Comm 1975; 65: 248-257
    CrossrefPubMedGoogle Scholar
  • 27 Takatsuki A, Kohno K, Tamura G. Inhibition of biosynthesis of polyisoprenol sugars in chick embryo microsomes by tunicamycin. Agr Biol Chem 1975; 39: 2089-2091
    PubMedGoogle Scholar
  • 28 Ashwell G, Morell AG. The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins. Adv Enzymol 1974; 41: 099-128
    PubMedGoogle Scholar
  • 29 Steer CJ, Clarenburg R. Unique distribution of glycoprotein receptors on parenchymal and sinusoidal cells of rat liver. J Biol Chem 1979; 254: 4457-4461
    PubMedGoogle Scholar
  • 30 Prieels J-P, Pizzo SV, Glasgow LR, Paulson JC, Hill RL. Hepatic receptor that specifically binds oligosaccharides containing fucosyl α1 → 3 N-acetylglucosamine linkages. Proc Natl Acad Sci USA 1978; 75: 2215-2219
    CrossrefPubMedGoogle Scholar
  • 31 Toth CA, Thomas P, Broitwan SA, Zamcheck N. A new Kupffer cell receptor mediating plasma clearance of carcinoembryonic antigen by the rat. Biochem J 1982; 204: 377-381
    CrossrefPubMedGoogle Scholar
  • 32 Imber MJ, Pizzo SV. Clearance and binding of native and defucosylated lactoferrin. Biochem J 1983; 212: 249-257
    CrossrefPubMedGoogle Scholar
  • 33 Fuchs HE, Shifman MA, Michalopoulos G, Pizzo SV. Hepatocyte receptors for antithrombin III-proteinase complexes. J Cell Biochem 1984; 24: 197-206
    CrossrefPubMedGoogle Scholar
  • 34 Robinson JH. Enzyme derivatives and their use in the treatment of thrombosis. Int Patent Application PCT/GB 83/00273 1983
    PubMedGoogle Scholar
  • 35 Levin EG. Latent tissue plasminogen activator produced by human endothelial cells in culture: evidence for an enzyme-inhibitor complex. Proc Natl Acad Sci USA 1983; 80: 6804-6808
    CrossrefPubMedGoogle Scholar
  • 36 Philips M, Juul AG, Thorsen S. Human endothelial cells produce a plasminogen activator inhibitor and a tissue-type plasminogen activator-inhibitor complex. Biochim Biophys Acta 1984; 802: 099-110
    CrossrefPubMedGoogle Scholar
  • 37 Fuchs HE, Berger H, Pizzo SV. Catabolism of human tissue plasminogen activator in mice. Blood 1985; 65: 539-544
    PubMedGoogle Scholar
  • 38 Rijken DC, Emeis JJ, Gerwig GJ. On the composition and function of the carbohydrate moiety of tissue-type plasminogen activator from human melanoma cells. Thromb Haemostas 1985 (in press)
    PubMedGoogle Scholar